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With interest, we read the recently published article by Proneth et al on the use of 
expanded criteria pancreas allografts and we congratulate the authors on the completion of 
this study.1 The study describes 79 pancreas transplantations, with 17 pancreata from donors 
between 50-60 years old and 1 pancreas from a donor with a Body Mass Index between 30-34 
kg/m2. The authors rightfully conclude that pancreas transplantations with organs from these 
‘older’ donors yield good outcome with similar graft survival. 
Due to organ shortage, increasing donor age is observed in all fields of transplantation. 
For pancreata, professionals are reluctant to accept organs from older donors, mostly due to 
the increased risk of graft thrombosis and pancreatitis. Despite these risks, the maximum donor 
age for acceptable pancreata in donation after brain death donors has in some countries 
already been expanded to 60 years old.2,3 Also, increasing numbers of donation after circulatory 
death pancreas transplantation are reported with excellent outcome.2,4 However, as authors 
state, due to legislation, this is not allowed in Germany. 
 Key elements incorporated for successful extension of donor limits by this study 
included local organ procurement to minimize ischemic time and the option to assess organ 
quality by the local team.1 All extended donor criteria (EDC) donors being explanted and 
transplanted by the 4 participating high-volume centers introduced a substantial bias. As also 
referred to by the authors, high-volume centers show better graft survival when transplanting 
pancreata with increased risk factors.5 Furthermore, experienced donor surgeons from 
pancreas transplant centers have a smaller risk of surgical organ injuries during abdominal 
organ recovery as compared to surgeons from centers not performing pancreas 
transplantation.6 
The inclusion of only 79 pancreata and 18 EDC pancreata in more than 3 years still 
suggests a very strict selection, reflected in a minimal extension of donor age with a mean of 
51.4  years old in the EDC group. Although being the strongest risk factor, there are more donor 
factors predicting outcome after transplantation. Axelrod et al weighed and combined these 
parameters in a continuous scoring tool: the Pancreas Donor Risk Index (PDRI).7 If calculated in 
this study, we hypothesize the PDRI would be about equal for both groups. Again, indicating a 
very strict donor selection for the EDC group. Therefore, it would have been interesting to also 
research the number and criteria of pancreata that were not accepted for transplantation 
within the study period. In general, some regions are more defensive in accepting organs than 
others.3 
The Extended Pancreas Donor Program (EXPAND) study shows that pancreata from 
donors over 50 years old can successfully be used for pancreas transplantation. Again, we 
congratulate the authors on their efforts to conduct this study and their publication. Hopefully, 
this initiative will be continued. With a mean donor age of just over 50 years old in the EDC 
group and the majority of transplantations being performed in low-volume centers, there seem 
to be options to even further expand the number of pancreas transplantations. 
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